Related Experiment Video
Updated: Jan 30, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Cholinergic forebrain density loss in Parkinson disease: More than just cognitive changes
Nicolaas I Bohnen1, Stefan J Teipel2
1From the Departments of Radiology (N.I.B.) and Neurology (N.I.B.), University of Michigan; VA Ann Arbor Healthcare System (N.I.B.), MI; German Center for Neurodegenerative Diseases (S.J.T.,) Rostock; and Department of Psychosomatic Medicine (S.J.T.), University of Rostock, Germany. nbohnen@umich.edu.
No abstract available in PubMed .
More Related Videos
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Cognitive Dissonance
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...